Stage IV Bladder Cancer Recruiting Phase 2 Trials for Afatinib (DB08916)

Also known as: Metastatic Bladder Cancer / Bladder cancer stage IV / Carcinoma urinary bladder stage IV / Urinary bladder carcinoma stage IV / Metastatic carcinoma of the bladder / Bladder carcinoma stage IV / Ca bladder stage IV / Carcinoma bladder stage IV

IndicationStatusPhase
DBCOND0028555 (Stage IV Bladder Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02122172Afatinib in Advanced Refractory Urothelial CancerTreatment